Related Experiment Video
Updated: Apr 19, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
[Cellular immune function and its clinical implications in 45 patients with multiple myeloma]
Mingxia Zhu1, Wenli Wan1, Jing Wang1
1Department of Hematology, Peking University Third Hospital, Beijing 100191, China.
Cellular immune function, including T cell and NK cell levels, is altered in multiple myeloma (MM) patients. These immune changes correlate with disease severity and prognosis, offering potential therapeutic targets.
Area of Science:
- Immunology
- Hematology
- Oncology
Background:
- Multiple myeloma (MM) is a hematologic malignancy characterized by uncontrolled proliferation of plasma cells.
- Cellular immune dysfunction is increasingly recognized as a critical factor in MM pathogenesis and progression.
- Understanding immune cell dynamics in MM is crucial for developing effective therapeutic strategies.
Purpose of the Study:
- To investigate the status of cellular immune function in patients with multiple myeloma (MM).
- To explore the clinical significance of these immune alterations in relation to disease stage and prognosis.
Main Methods:
- Flow cytometry was used to analyze T cell subtypes, natural killer (NK) cells, dendritic cells (DC), helper T cells (Th1, Th2), regulatory T cells (Treg), and Th17 cells in 45 MM patients.
- Patients were categorized into newly diagnosed, stable stage, and relapsed/refractory groups.
- Serum levels of β2 microglobulin (β2-MG), lactate dehydrogenase (LDH), and hemoglobin (Hb) were measured.
Main Results:
- Newly diagnosed and relapsed/refractory MM patients exhibited significantly lower ratios of CD4+/CD8+, DC1/DC2, and Th1/Th2, along with reduced Treg and NK cell counts compared to controls and stable patients.
- The IL-17A/Treg ratio was significantly higher in newly diagnosed and relapsed/refractory groups, and in patients with higher International Staging System (ISS) stages.
- Negative correlations were observed between CD4+/CD8+, DC1/DC2, Th1/Th2 ratios and β2-MG/LDH levels, while the IL-17A/Treg ratio positively correlated with these markers.
Conclusions:
- Abnormalities in CD4+/CD8+, DC1/DC2, Th1/Th2 ratios, and the IL-17A/Treg balance are closely associated with disease progression and severity in MM.
- These immune dysregulations are linked to treatment outcomes, disease progression, and overall prognosis in MM patients.
- The findings highlight the potential of immune profiling for predicting MM patient outcomes and guiding therapeutic interventions.
More Related Videos
Related Concept Videos
Cell-mediated Immune Responses
Differentiation of Common Myeloid Progenitor Cells
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

